On Tuesday, Deutsche Telekom AG unveiled the first smart phone that will use Google’s new Android operating system.  The device is called the G1, sold by Deutsche Telekom’s subsidiary T-Mobile, and it looks a lot like the iPhone and other competing smart phones (well, except for the Google logo on the back).  But its the software, not the hardware, that T-Mobile and Google hope will set this new product apart. It will need to be special to crack the dominance of RIMM’s Blackberry and Apple’s iPhone in the smart phone market.  Those two companies controlled a combined 65% of the market in 2008, ahead of a long list of competitors that also includes PALM, Motorola, LG, and Samsung.

But smart phone users are savvy folks, and they’re looking for devices that will make life more efficient, and more enjoyable.  That’s where the cache of Google’s

Nutrition 21 Inc. (NXXI:NASDAQ) is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. The company holds more than 30 patents for nutrition products and uses.

Nutrition 21’s portfolio of health and wellness products include: Iceland Health Chromax, Iceland Health Joint Relief, Iceland Health Advanced Memory Formula, Iceland Health Maximum Strength Omega-3, and Diabetes Essentials. The company distributes its products nationally through more than 29,000 major food, drug, and super center stores throughout the US and internationally.

On September 11th, 2008 Nutrition 21 reported that study results released by the US government’s National Toxicology Program support the safety of short-term and long-term use of Chromax chromium picolinate. Multiple safety studies were performed in animals, including a two-year study using daily dose of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.

Nutrition 21 vice-president James Komorowski,